|
|
|
|
| Top Story |
 |
|
China's Biopharma Rise |
Peter Young explores the prospects—and related challenges—for Chinese life science as it aggressively pursues new growth areas
... /Read more/ |
|
|
|
| Calendar |
|
/ August 7–8: Bio/Pharma Compliance Congress on Non-Promotional Activities / |
|
Philadelphia, PA |
|
/ September 13–14: Global Risk Based Monitoring / |
|
London, UK |
|
/ October 2–3: Advanced Therapies Commercialization Congress / |
|
Amsterdam, The Netherlands |
|
/ October 15–17: 28th Annual Sharing Conference: Compliance / |
|
National Harbor, MD |
|
/ November 13–14: Due Diligence for Life Sciences M&A, Partnerships and Divestitures / |
|
Philadelphia, PA |
|
/ November 14–15: Commercial Data Insights 2018 / |
|
Philadelphia, PA |
|
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences / |
|
London, UK |
|
/ November 28–29: Compliant Patient Support Programs Summit / |
|
Chicago, IL |
|
/ December 4–5: Managed Markets Compliance Congress
2018
/ |
|
Philadelphia, PA |
|
|
|
| Industry update |
|
//
Tissue Regenix Group (Leeds, UK) appointed Gareth Hywel Jones as Chief Financial Officer. He will join the Group as CFO, Company Secretary and as an Executive Director on the Board on November 30, 2018.
//
Crescendo Biologics Ltd (Cambridge, UK) appointed Igor Matushansky, M.D., Ph.D., and Lotta Allan as Non-Executive Directors.
//
Concept Life Sciences (Manchester, UK) appointed John Vu as Business Development Director for the West Coast, to further expand the group's presence in and support for the US market.
//
Paul Kinnon was appointed CEO of PredictImmune (Cambridge, UK).
//
Sanofi appointed Jean-Baptiste Chasseloup de Chatillon as Executive Vice President, Chief Financial Officer and Member of the Executive Committee, effective October 1, 2018. He will join Sanofi on September 1 to ensure a smooth transition with Jérôme Contamine who will retire on September 30.
//
iTeos Therapeutics (Gosselies, Belgium) appointed Scott Chappel, Ph.D., as Chief Scientific Officer. The company also announced the appointment of David Hallal and Tim Van Hauwermeiren to its Board of Directors.
//
Xellia Pharmaceuticals (Copenhagen, Denmark) appointed Matthew Anderson as Chief Financial Officer.
//
EuropaBio's (Brussels, Belgium) Executive Board and General Assembly of Members confirmed the appointment of Tjerk de Ruiter as Chairman of the Association.
|
|
|
|
